News

Rubin and Rudman Welcomes Dawn Stolfi Stalenhoef as Partner

Rubin and Rudman Welcomes Dawn Stolfi Stalenhoef as Partner

Exciting New Addition to Rubin and Rudman

Rubin and Rudman is thrilled to announce that Dawn Stolfi Stalenhoef has joined the firm as a partner within its Environmental, Land Use & Zoning practice group. With an impressive 25-year career dedicated to environmental and land use law, Dawn brings significant expertise in complex commercial real estate transactions and project development. Her extensive background includes working on brownfields redevelopment, hazardous waste management, solid waste, and compliance counseling for regulatory issues.

Extensive Legal Experience

Before joining Rubin and Rudman, Stolfi Stalenhoef was a partner at Casner & Edwards. Her legal journey has seen her excel in both the private and public sectors. Notably, she has served as Chief Regional Counsel for the southeast regional office of the Massachusetts Department of Environmental Protection and held the position of Assistant Attorney General in the Environmental Protection Division of the Massachusetts Attorney General's Office. Over the years, Stolfi Stalenhoef has also showcased her talent as an environmental scientist prior to her law career, working at Metcalf & Eddy.

Comments from Leadership

In welcoming Dawn to the firm, John J. McGivney, the managing partner at Rubin and Rudman, expressed, "We are always looking for high-level lateral talent to add to our team and are thrilled to welcome Dawn to our firm. She is one of the most experienced and respected environmental attorneys in this region and brings a wealth of knowledge to our real estate and environmental bench." This sentiment reflects the firm's commitment to enhancing its offerings in environmental law.

Community Involvement

Stolfi Stalenhoef is not just a legal expert but also an active participant in her community and industry organizations. She currently serves as a Director for the Needham Land Trust, Inc. Her previous leadership roles include serving as a Director for the Massachusetts Association of Conservation Commissions and Co-Chair for the Boston Bar Association’s Wetlands and Waterways Committee under the Environment and Energy Section. Moreover, she is a member of various professional and public service organizations, including the Licensed Site Professionals Association and the Real Estate Bar Association, Massachusetts Chapter.

Recognitions and Academic Background

In recognition of her contributions, Stolfi Stalenhoef was honored in 2023 as one of Massachusetts Lawyers Weekly's "Top Women of Law." Her academic credentials are impressive as well; she earned her Juris Doctorate, graduating cum laude, from Suffolk University Law School. Additionally, she holds a Master’s degree in Environmental Studies from Simmons College and a Bachelor’s degree from Merrimack College.

About Rubin and Rudman LLP

Founded over a century ago, Rubin and Rudman has grown into a prominent full-service law firm with a team of nearly 100 lawyers. The firm is headquartered in Boston, Massachusetts, and boasts a diverse practice, serving a variety of clients from national and international companies to real estate developers, educational institutions, and individuals. They are equipped to cater to various legal needs, demonstrating their commitment to excellence in service and community support. In addition to their Boston office, Rubin and Rudman has suburban locations in Andover and Woburn, Massachusetts.

Frequently Asked Questions

Who is Dawn Stolfi Stalenhoef?

Dawn Stolfi Stalenhoef is a newly appointed partner at Rubin and Rudman, specializing in Environmental, Land Use, and Zoning law, with over 25 years of experience.

What prior roles has Stolfi Stalenhoef held?

Before joining Rubin and Rudman, she was a partner at Casner & Edwards and served in positions with the Massachusetts Department of Environmental Protection and as an Assistant Attorney General.

What is Rubin and Rudman known for?

Rubin and Rudman is known for being a full-service law firm with a diverse practice, representing large corporations, real estate developers, and individuals in various legal contexts.

Where does Rubin and Rudman have offices?

Rubin and Rudman has its main office in Boston, Massachusetts, and also has suburban offices in Andover and Woburn.

What community roles does Stolfi Stalenhoef currently hold?

She is currently a Director of the Needham Land Trust, Inc., among other community and professional affiliations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Can Take Charge in Outset Medical Securities Case

Updated Category News Views 226

Investors Can Take Control in Outset Medical Securities Case Investors seeking justice now have a valuable opportunity to take the lead in a class action lawsuit against Outset Medical, Inc. (NASDAQ: OM). This legal effort arises from claims suggesting that the company may not have been fully transparent about its product marketing and operational practices. Understanding...

Continue Reading
Understanding Market Dynamics for IDEXX Laboratories (IDXX)

Updated Category News Views 140

Insights into IDEXX Laboratories Option Trading In recent times, there has been a notable bearish sentiment among major investors regarding IDEXX Laboratories. Taking a closer look at the trading activities surrounding this stock, our attention shifts towards its options market dynamics. Recent Trading Patterns Analyzing the options history for IDEXX Laboratories (NASDAQ:...

Continue Reading
Upcoming Earnings Reports and Market Insights for Investors

Updated Category News Views 164

Key Companies Reporting Earnings Soon As investors gear up for a busy earnings week, a variety of companies are set to disclose their quarterly results. These reports often provide valuable insights into business performance and market trends. Companies Scheduled to Report Before Market Opens So-Young International Inc (NASDAQ: SY) So-Young is anticipated to announce its...

Continue Reading
Intelligent Alpha Launches Innovative AI-Driven ETF for Investors

Updated Category News Views 269

Welcome to Intelligent Alpha and AI-Driven Investments In today's fast-paced investment world, Doug Clinton, co-founder and Managing Partner at Deepwater Asset Management, has introduced Intelligent Alpha, a groundbreaking investment firm focused on utilizing the power of artificial intelligence. This unique firm distinguishes itself by having an investment committee that...

Continue Reading
Investors of Lineage, Inc. (LINE) Consider Class Action Suit

Updated Category News Views 141

Class Action Lawsuit Against Lineage, Inc. In the financial landscape, every investor hopes to see growth in their investments. However, recent developments with Lineage, Inc. have prompted concern among shareholders. It has come to light that some investors may have sustained losses due to alleged securities fraud surrounding the company's performance. As a result, legal...

Continue Reading